451 related articles for article (PubMed ID: 16890614)
21. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
[TBL] [Abstract][Full Text] [Related]
22. Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.
Soroka CJ; Boyer JL
Mol Aspects Med; 2014 Jun; 37():3-14. PubMed ID: 23685087
[TBL] [Abstract][Full Text] [Related]
23. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene.
Wasmuth HE; Glantz A; Keppeler H; Simon E; Bartz C; Rath W; Mattsson LA; Marschall HU; Lammert F
Gut; 2007 Feb; 56(2):265-70. PubMed ID: 16891356
[TBL] [Abstract][Full Text] [Related]
24. [Childhood cholestasis and bile transporters].
Hierro L; Jara P
Gastroenterol Hepatol; 2005; 28(7):388-95. PubMed ID: 16137474
[TBL] [Abstract][Full Text] [Related]
25. Bile salt export pump (BSEP/ABCB11): trafficking and sorting disturbances.
Hayashi H; Sugiyama Y
Curr Mol Pharmacol; 2013 Jul; 6(2):95-103. PubMed ID: 23876151
[TBL] [Abstract][Full Text] [Related]
26. The bile salt export pump (BSEP) in health and disease.
Kubitz R; Dröge C; Stindt J; Weissenberger K; Häussinger D
Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):536-53. PubMed ID: 22795478
[TBL] [Abstract][Full Text] [Related]
27. Combined functional variants of hepatobiliary transporters and FXR aggravate intrahepatic cholestasis of pregnancy.
Zimmer V; Müllenbach R; Simon E; Bartz C; Matern S; Lammert F
Liver Int; 2009 Sep; 29(8):1286-8. PubMed ID: 19490418
[No Abstract] [Full Text] [Related]
28. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.
Strautnieks SS; Byrne JA; Pawlikowska L; Cebecauerová D; Rayner A; Dutton L; Meier Y; Antoniou A; Stieger B; Arnell H; Ozçay F; Al-Hussaini HF; Bassas AF; Verkade HJ; Fischler B; Németh A; Kotalová R; Shneider BL; Cielecka-Kuszyk J; McClean P; Whitington PF; Sokal E; Jirsa M; Wali SH; Jankowska I; Pawłowska J; Mieli-Vergani G; Knisely AS; Bull LN; Thompson RJ
Gastroenterology; 2008 Apr; 134(4):1203-14. PubMed ID: 18395098
[TBL] [Abstract][Full Text] [Related]
29. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
30. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E
Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
[TBL] [Abstract][Full Text] [Related]
31. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
[TBL] [Abstract][Full Text] [Related]
32. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
[TBL] [Abstract][Full Text] [Related]
33. Progressive familial intrahepatic cholestasis with high gamma-glutamyltranspeptidase levels in Taiwanese infants: role of MDR3 gene defect?
Chen HL; Chang PS; Hsu HC; Lee JH; Ni YH; Hsu HY; Jeng YM; Chang MH
Pediatr Res; 2001 Jul; 50(1):50-5. PubMed ID: 11420418
[TBL] [Abstract][Full Text] [Related]
34. [Liver disease associated with hereditary defects of hepatobiliary transporters].
Wendum D
Ann Pathol; 2010 Dec; 30(6):426-31. PubMed ID: 21167428
[TBL] [Abstract][Full Text] [Related]
35. The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease.
Lam P; Soroka CJ; Boyer JL
Semin Liver Dis; 2010 May; 30(2):125-33. PubMed ID: 20422495
[TBL] [Abstract][Full Text] [Related]
36. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
Hayashi H; Sugiyama Y
Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
[TBL] [Abstract][Full Text] [Related]
37. Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.
Lam P; Pearson CL; Soroka CJ; Xu S; Mennone A; Boyer JL
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1709-16. PubMed ID: 17855769
[TBL] [Abstract][Full Text] [Related]
38. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
Stieger B
Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
[TBL] [Abstract][Full Text] [Related]
39. [Recurrent intrahepatic cholestasis of pregnancy and chain-like choledocholithiasis in a female patient with stop codon in the ABDC4-gene of the hepatobiliary phospholipid transporter].
Muehlenberg K; Wiedmann K; Keppeler H; Sauerbruch T; Lammert F
Z Gastroenterol; 2008 Jan; 46(1):48-53. PubMed ID: 18188816
[TBL] [Abstract][Full Text] [Related]
40. The bile salt export pump.
Stieger B; Meier Y; Meier PJ
Pflugers Arch; 2007 Feb; 453(5):611-20. PubMed ID: 17051391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]